BHC - Bausch Health Companies Inc.
NYSE
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Laval,
Canada
Type: Equity
BHC price evolution
BHC
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $962 | $780 | $588 | $531 |
| Short term investments | ||||
| Net receivables | $1998 | $1948 | $1743 | $1688 |
| Inventory | $1544 | $1272 | $1240 | $1222 |
| Total current assets | $5596 | $5048 | $4461 | $4237 |
| Long term investments | ||||
| Property, plant & equipment | $1707 | $1584 | $1599 | $1596 |
| Goodwill & intangible assets | $17639 | $17915 | $16927 | $17131 |
| Total noncurrent assets | $21754 | $22016 | $21042 | $21208 |
| Total investments | ||||
| Total assets | $27350 | $27064 | $25503 | $25445 |
| Current liabilities | ||||
| Accounts payable | $719 | $569 | $515 | $561 |
| Deferred revenue | ||||
| Short long term debt | $450 | $536 | $444 | $446 |
| Total current liabilities | $4302 | $4224 | $3967 | $3923 |
| Long term debt | $21938 | $21894 | $20108 | $20207 |
| Total noncurrent liabilities | $23130 | $23075 | $21265 | $21377 |
| Total debt | $22388 | $22430 | $20552 | $20653 |
| Total liabilities | $27432 | $27299 | $25232 | $25300 |
| Shareholders' equity | ||||
| Retained earnings | -$9778 | -$9739 | -$9361 | -$9387 |
| Other shareholder equity | -$1881 | -$2051 | -$1902 | -$1989 |
| Total shareholder equity | -$1022 | -$1180 | -$663 | -$800 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $962 | $591 | $2119 | $1816 |
| Short term investments | ||||
| Net receivables | $1998 | $1790 | $1775 | $1577 |
| Inventory | $1544 | $1090 | $993 | $1094 |
| Total current assets | $5596 | $4247 | $5607 | $5342 |
| Long term investments | ||||
| Property, plant & equipment | $1707 | $1821 | $1598 | $1567 |
| Goodwill & intangible assets | $17639 | $17347 | $19405 | $21489 |
| Total noncurrent assets | $21754 | $21439 | $23595 | $25857 |
| Total investments | ||||
| Total assets | $27350 | $25686 | $29202 | $31199 |
| Current liabilities | ||||
| Accounts payable | $719 | $521 | $407 | $337 |
| Deferred revenue | ||||
| Short long term debt | $450 | $432 | ||
| Total current liabilities | $4302 | $3941 | $5198 | $4913 |
| Long term debt | $21938 | $20334 | $22654 | $23925 |
| Total noncurrent liabilities | $23130 | $21485 | $24038 | $25681 |
| Total debt | $22388 | $20766 | $22654 | $23925 |
| Total liabilities | $27432 | $26378 | $29236 | $30594 |
| Shareholders' equity | ||||
| Retained earnings | -$9778 | -$9186 | -$8961 | -$8013 |
| Other shareholder equity | -$1881 | -$2056 | -$1924 | -$2133 |
| Total shareholder equity | -$1022 | -$692 | -$106 | $535 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2408 | $2238 | $2167 | $1944 |
| Cost of revenue | $705 | $623 | $649 | $582 |
| Gross Profit | $1703 | $1615 | $1518 | $1362 |
| Operating activities | ||||
| Research & development | $152 | $153 | $156 | $143 |
| Selling, general & administrative | $766 | $715 | $711 | $725 |
| Total operating expenses | $1341 | $1601 | $1106 | $1187 |
| Operating income | $362 | $14 | $412 | $175 |
| Income from continuing operations | ||||
| EBIT | $364 | $17 | $397 | $179 |
| Income tax expense | $40 | $56 | $52 | $73 |
| Interest expense | $363 | $339 | $319 | $307 |
| Net income | ||||
| Net income | -$39 | -$378 | $26 | -$201 |
| Income (for common shares) | -$39 | -$378 | $26 | -$201 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $8757 | $8124 | $8434 | $8027 |
| Cost of revenue | $2559 | $2364 | $2394 | $2249 |
| Gross Profit | $6198 | $5760 | $6040 | $5778 |
| Operating activities | ||||
| Research & development | $604 | $529 | $465 | $452 |
| Selling, general & administrative | $2917 | $2625 | $2624 | $2367 |
| Total operating expenses | $5235 | $5306 | $5590 | $5102 |
| Operating income | $963 | $454 | $450 | $676 |
| Income from continuing operations | ||||
| EBIT | $957 | $1322 | $391 | $599 |
| Income tax expense | $221 | $83 | -$87 | -$375 |
| Interest expense | $1328 | $1464 | $1426 | $1534 |
| Net income | ||||
| Net income | -$592 | -$225 | -$948 | -$560 |
| Income (for common shares) | -$592 | -$225 | -$948 | -$560 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$39 | -$378 | $26 | -$201 |
| Operating activities | ||||
| Depreciation | $329 | $301 | $315 | $319 |
| Business acquisitions & disposals | -$3 | -$1852 | $1 | -$31 |
| Stock-based compensation | $29 | $29 | $33 | $41 |
| Total cash flows from operations | $390 | $282 | $206 | $154 |
| Investing activities | ||||
| Capital expenditures | -$144 | -$46 | -$31 | -$51 |
| Investments | -$1 | $2 | -$2 | |
| Total cash flows from investing | -$148 | -$1889 | -$30 | -$78 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$24 | |||
| Net borrowings | -$57 | $1838 | -$112 | -$124 |
| Total cash flows from financing | -$79 | $1816 | -$120 | -$142 |
| Effect of exchange rate | $19 | -$17 | $1 | $6 |
| Change in cash and equivalents | $182 | $192 | $57 | -$60 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$592 | -$225 | -$948 | -$560 |
| Operating activities | ||||
| Depreciation | $1264 | $1394 | $1552 | $1825 |
| Business acquisitions & disposals | -$1885 | -$40 | $669 | $21 |
| Stock-based compensation | $132 | $126 | $128 | $105 |
| Total cash flows from operations | $1032 | -$728 | $1426 | $1111 |
| Investing activities | ||||
| Capital expenditures | -$272 | -$268 | -$283 | -$309 |
| Investments | -$1 | $5 | -$4 | $4 |
| Total cash flows from investing | -$2145 | -$303 | $409 | -$261 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$24 | -$31 | -$52 | -$30 |
| Net borrowings | $1545 | -$1081 | -$1388 | -$2226 |
| Total cash flows from financing | $1475 | -$474 | -$1513 | -$2294 |
| Effect of exchange rate | $9 | -$23 | -$19 | $16 |
| Change in cash and equivalents | $371 | -$1528 | $303 | -$1428 |
News
Fundamentals
| Market cap | $3.09B |
|---|---|
| Enterprise value | $24.51B |
| Shares outstanding | 365.24M |
| Revenue | $8.76B |
|---|---|
| EBITDA | $2.22B |
| EBIT | $957.00M |
| Net Income | -$592.00M |
| Revenue Q/Q | 9.80% |
| Revenue Y/Y | 7.79% |
| P/E ratio | -5.21 |
|---|---|
| EV/Sales | 2.80 |
| EV/EBITDA | 11.04 |
| EV/EBIT | 25.61 |
| P/S ratio | 0.35 |
| P/B ratio | 3.59 |
| Book/Share | 2.35 |
| Cash/Share | 2.63 |
| EPS | -$1.62 |
|---|---|
| ROA | -2.25% |
| ROE | 64.61% |
| Debt/Equity | -26.84 |
|---|---|
| Net debt/EBITDA | 11.92 |
| Current ratio | 1.30 |
| Quick ratio | 0.94 |